Source: https://litigationconferences.com/reversed-remanded-the-impact-of-recent-appellate-court-rulings-on-mass-torts-sept-18-2017-complimentary-cle-eligible/
Timestamp: 2019-04-20 17:14:20+00:00

Document:
Judge Corodemus is referring to a spate of rulings this year that are significant to mass tort attorneys everywhere.
In its BNSF Railway Co. v. Tyrrell decision, the Supreme Court held that its general jurisdiction holding in Daimler AG v. Bauman wasn’t limited to only certain types claims. Shortly after that the high court handed down its much-anticipated jurisdiction ruling in Bristol-Myers Squibb v. Superior Court, a win for defendants who had argued against litigation in states in which they are neither incorporated nor do business.
The New Jersey Supreme Court’s statute of limitations decision in McCarrell v. Hoffmann-La Roche.
The New Jersey Appellate Division’s two decisions in the In re Accutane Litigation found lower court errors in evidentiary rulings on science, causation and warnings. July 25, 2017 decision. July 28, 2017 decision.
The Third Circuit U.S. Court of Appeals revived thousands of cases in In re: Fosamax Products Liability Litigation, finding that the trial court had improperly granted summary judgement on preemption grounds by misapplying the Supreme Court’s “clear evidence” standard in Wyeth v. Levine.
Because of these developments the judge has impaneled a group of experts to share their insights during a 90-minute educational webinar.
Review the case history of these seminal decisions.
Analyze the meaning and impact of the courts’ holdings.
Discuss critical issues now before many courts on specific personal jurisdiction and general jurisdiction.
Debate the future of these cases and whether they represent a change for the better.
Comment on whether class actions are changed forever.
Predict – as best they can – the real impact of these cases.
Ellen Relkin, Weitz & Luxenberg, P.C.
State Court Jurisdiction in the 21st Century by Prof. Adam N. Steinman for the Pound Civil Justice Institute. Download it now.
An Assessment of the Real World Implications of the New Jersey Supreme Court’s McCarrell Decision by William J. Beausoleil of Hughes Hubbard & Reed LLP. Read it now.
Accutane Plaintiffs Overcome the “Super-Presumption” That FDA-Approved Warnings About Drugs are Adequate by Bruce D. Greenberg, Lite DePalma Greenberg, LLC. Read it now.
Another Accutane Decision and a Big Win for Plaintiffs by Greenberg. Read it now.
Merck’s petition to the U.S. Supreme Court in Merck Sharp & Dohme v. Albrecht on the issue of whether FDA approval insulates it from state law failure-to-warn claims. Read it now.
The Supreme Court’s 2009 ruling against preemption of state law failure-to-warn claims in Wyeth v. Levine. Read it now.
The Third Circuit U.S. Court of Appeals’ March 2017 ruling in In Re: Fosamax Product Liability Litigation which allowed the plaintiffs to proceed with state law failure-to-warn claims. Read it now.
Northfolk Southern v. Dolan, an en banc decision from the Missouri Supreme Court denying jurisdiction over the case basically saying that running railroad tracks through the state is not enough of a connection. Read it now.
The Missouri Supreme Court’s one-page writ order in Imerys Talc America, denying jurisdiction without prejudice to nonresident plaintiffs. Read it now.
Covington v. Janssen, a memorandum and order from the U.S. District Court in Missouri’s Eastern District denying jurisdiction and citing the BMS decision. Read it now.
A special thanks to JAMS Resolution Center in New York for hosting this panel as they gather to share their insights via this webinar.
This webinar is part of a series of programs leading up to the judge’s 2018 event.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.